Scientific research has been at the heart of every breakthrough we’ve made in the fight against HIV and in order to stop HIV we need convenient, safe, and effective prevention options. As we search for innovative solutions to guide HIV prevention, we continue to conduct clinical trials of promising strategies to understand their effectiveness and safety across different populations at risk for HIV infection.
Groundbreaking research—the kind we need for HIV—must include diverse participants from all parts of the community. Although many research projects lack critical community voices, HelpFightHIV.org and Bridge HIV are committed to inclusive research studies. We must be at the table to make sure we are served well! Our fight against HIV is focused on achieving health equity for all so our research must be too.
Our innovative research is focused on helping fight HIV through several strategies, so whether it’s an HIV vaccine, a new way to do HIV testing or a new pill to prevent HIV, the goal is the same.
But, we need your help. Check out our current studies below and volunteer today!
We are currently enrolling the following studies:
Mosaico is a global study testing 2 HIV vaccines to see if it protects transgender people and cis-gender men who have sex with men against infection with HIV.
The study will enroll HIV-negative transgender individuals and cis-gender men, age 18 to 60, who have sex with other cis-gender men or transgender people, and have chosen not to use Pre-exposure Prophylaxis (PrEP) to prevent HIV infection.
Participants will receive four injections over the course of a year, assigned to either the vaccines or placebo. Total time in the study will be at least 30 months. Eligible participants receive $75-$125 per study visit and HIV testing and counseling.
The PHASTT Study will test a new mobile app, Sex Pro, which was designed to connect men like you to HIV and STD testing services, including at-home HIV/STD testing, Pre-Exposure Prophylaxis (PrEP), and other HIV care services.
The Study will enroll black men, 18-29, who have sex with other men. Study participation will consist of completing three surveys over a 6-month period. Eligible participants earn up to $275 if they complete all study procedures.
Active studies related to HIV cure science (including therapeutic vaccines) are conducted by our AIDS Clinical Trials Group (ACTG) partners at the Positive Health Program at the University of California, San Francisco.
Their studies range from strategies to address HIV-associated inflammation, innovative antiretroviral therapy treatment including regimen simplification / injectable medications, and optimization of treatment for complications related to co-infections. In addition, they have active research in tuberculosis and viral hepatitis (both hepatitis B and C) for people living with or without HIV.
For more information about actively enrolling studies, please call or text Dan Berrner at (415) 535-9495 or email him at email@example.com.